These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23649101)

  • 1. Neural repair and rehabilitation: Fibroblast-derived OPCs--hope for remyelination therapy?
    Malpass K
    Nat Rev Neurol; 2013 Jun; 9(6):299. PubMed ID: 23649101
    [No Abstract]   [Full Text] [Related]  

  • 2. White matter from fibroblasts.
    Goldman SA
    Nat Biotechnol; 2013 May; 31(5):412-3. PubMed ID: 23657393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing one cell type into another.
    de Souza N
    Nat Methods; 2013 Jun; 10(6):459. PubMed ID: 23866329
    [No Abstract]   [Full Text] [Related]  

  • 4. Generation of oligodendroglial cells by direct lineage conversion.
    Yang N; Zuchero JB; Ahlenius H; Marro S; Ng YH; Vierbuchen T; Hawkins JS; Geissler R; Barres BA; Wernig M
    Nat Biotechnol; 2013 May; 31(5):434-9. PubMed ID: 23584610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
    Najm FJ; Lager AM; Zaremba A; Wyatt K; Caprariello AV; Factor DC; Karl RT; Maeda T; Miller RH; Tesar PJ
    Nat Biotechnol; 2013 May; 31(5):426-33. PubMed ID: 23584611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression.
    Plemel JR; Manesh SB; Sparling JS; Tetzlaff W
    Glia; 2013 Sep; 61(9):1471-87. PubMed ID: 23839973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.
    Nakahara J; Kanekura K; Nawa M; Aiso S; Suzuki N
    J Clin Invest; 2009 Jan; 119(1):169-81. PubMed ID: 19104151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy inhibits remyelination in the central nervous system.
    Miron VE; Zehntner SP; Kuhlmann T; Ludwin SK; Owens T; Kennedy TE; Bedell BJ; Antel JP
    Am J Pathol; 2009 May; 174(5):1880-90. PubMed ID: 19349355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal IgM influence oligodendrocyte precursor cells in mixed glial cell cultures: implications for remyelination.
    Stangel M; Bernard D
    J Neuroimmunol; 2003 May; 138(1-2):25-30. PubMed ID: 12742649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional and post-transcriptional control of CNS myelination.
    Emery B
    Curr Opin Neurobiol; 2010 Oct; 20(5):601-7. PubMed ID: 20558055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo.
    Talbott JF; Cao Q; Bertram J; Nkansah M; Benton RL; Lavik E; Whittemore SR
    Exp Neurol; 2007 Mar; 204(1):485-9. PubMed ID: 17274982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.
    Alizadeh A; Karimi-Abdolrezaee S
    J Physiol; 2016 Jul; 594(13):3539-52. PubMed ID: 26857216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators of oligodendrocyte differentiation during remyelination.
    Patel JR; Klein RS
    FEBS Lett; 2011 Dec; 585(23):3730-7. PubMed ID: 21539842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells as potential nerve therapy.
    Steghaus-Kovac S
    Science; 1999 Jul; 285(5428):650-1. PubMed ID: 10454911
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
    Doucette JR; Jiao R; Nazarali AJ
    Cell Mol Neurobiol; 2010 May; 30(4):607-29. PubMed ID: 20063055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrical signalling properties of oligodendrocyte precursor cells.
    Bakiri Y; Attwell D; Káradóttir R
    Neuron Glia Biol; 2009 May; 5(1-2):3-11. PubMed ID: 19674511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the oligodendrogenic program of neural progenitors: cell intrinsic and extrinsic regulators.
    Rivera FJ; Steffenhagen C; Kremer D; Kandasamy M; Sandner B; Couillard-Despres S; Weidner N; Küry P; Aigner L
    Stem Cells Dev; 2010 May; 19(5):595-606. PubMed ID: 19938982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural stem cells as a potential source of oligodendrocytes for myelin repair.
    Chandran S; Compston A
    J Neurol Sci; 2005 Jun; 233(1-2):179-81. PubMed ID: 15907942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.